SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015249
Filing Date
2022-08-08
Accepted
2022-08-08 07:31:10
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vigl-20220630.htm   iXBRL 10-Q 2754059
2 EX-31.1 vigl-ex31_1.htm EX-31.1 23021
3 EX-31.2 vigl-ex31_2.htm EX-31.2 22985
4 EX-32.1 vigl-ex32_1.htm EX-32.1 14337
5 EX-32.2 vigl-ex32_2.htm EX-32.2 14319
  Complete submission text file 0000950170-22-015249.txt   8703744

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vigl-20220630.xsd EX-101.SCH 64175
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vigl-20220630_lab.xml EX-101.LAB 488008
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vigl-20220630_cal.xml EX-101.CAL 44017
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vigl-20220630_pre.xml EX-101.PRE 403648
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vigl-20220630_def.xml EX-101.DEF 284208
60 EXTRACTED XBRL INSTANCE DOCUMENT vigl-20220630_htm.xml XML 1316276
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41200 | Film No.: 221142575
SIC: 2836 Biological Products, (No Diagnostic Substances)